市場調査レポート

商品コード

凝固市場規模および予測、世界および地域シェア、動向、成長機会分析レポート対象範囲：適応疾患別、タイプ別、オファリング別、技術別、エンドユーザー別、地域別

Coagulation Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Indications, Type, Offering, Technology, End User, and Geography

出版日: 2023年10月11日
発行: The Insight Partners
ページ情報: 英文 250 Pages
納期: 即納可能

価格

PDF (Single User License)

USD 4,450 653,349円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,450 946,989円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,450 1,240,629円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

凝固市場は、2022年の62億9,500万米ドルから2030年には108億5,300万米ドルに成長すると予想されており、2022年から2030年までのCAGRは7.0%を記録すると予測されています。

生活習慣の変化と高齢者人口の増加は、血液疾患の有病率を高める主な要因のひとつです。そのため、早期診断と早期治療に対する需要が高まっています。主要企業は、患者集団の生活の質を高めるために、有機的・無機的なさまざまな戦略を通じて、いくつかの取り組みを行っています。

2020年7月、Sysmex Corporationは自動血液凝固分析装置CN-6500/CN-3500を日本で発売しました。この分析装置は血液凝固・血小板凝集パラメータ、血栓症・止血パラメータを測定します。

2020年4月、米国のHaemonetics Corporationは血液凝固診断システム開発会社のEnicorを買収しました。

2021年10月、Trivitron HealthcareはインドのDiagon Ltdが製造する新しい凝固分析装置製品ラインを発売。

2021年6月、Trivitron Healthcareは糖尿病、ヘモグロビン変動、サラセミアのモニタリングに役立つNANO H5とNANO H110を発表。

2021年2月、Siemens HealthineersとSysmex Corporationは、全世界における止血製品の供給、流通、販売、サービスに関する契約を更新しました。この契約には複数年の延長も含まれています。さらに、Siemens Healthineersは、Sysmex Corporationの自動血液凝固分析装置CN-3000およびCN-6000の販売にも合意しました。

2022年7月、HORIBA Medicalは最新の止血分析装置「Yumizen G800」と「G1550」、および一般的な血液凝固検査に便利な即使用可能な試薬を発売しました。この製品ラインアップの拡充により、HORIBA Medicalは、あらゆる規模や要件の検査室向けに、包括的な止血システムと高度な試薬のセレクションを提供することになっています。

このように、主要市場参入企業による有機的・無機的なさまざまな戦略の採用は、予測期間中に凝固市場の成長機会をもたらすと期待されます。

心血管疾患の有病率の上昇が凝固市場の成長を牽引

心疾患は、心房細動や脳卒中などの状態による入院、死亡、身体能力の低下の主な原因の1つです。心臓病は止血系、血管系、血液の流体力学に影響を及ぼし、動脈血栓症や静脈血栓症を引き起こします。血栓症は心血管系疾患による死亡および合併症の主な原因です。喫煙や高血圧によって損傷を受けた血管は、血管を覆うコレステロールを多く含むプラークを形成し、これが破裂して血小板が凝固することがあります。凝固障害では、心筋梗塞、脳卒中、血管床でのアテローム血栓性イベントのリスクがあります。心不全（HF）は心房細動（AF）の有無とは無関係に血栓塞栓症のリスク上昇に関係します。血小板の活性化や凝固系の異常は、心不全患者における重篤な血栓塞栓症のリスクを増大させる。

2022 Heart Disease &Stroke Statistical Update Fact Sheetによると、2020年には世界中でCVDによる死亡が1億1,910万人、脳卒中と虚血性脳卒中の症例がそれぞれ8,910万人と6,820万人記録されています。National Center for Chronic Disease Prevention and Health Promotionによると、2023年、米国では毎年87万7,500人が心臓病で死亡すると報告されています。米国心臓協会によると、2035年までに1億3,000万人以上のアメリカ人が何らかの形でCVDを発症する可能性があります。Global Burden of Disease Study 2019』によると、2019年のアジア太平洋における死亡原因の第1位はCVDであり、死亡者全体の35％にあたる1,080万人を引き起こしています。

凝固検査は、心臓発作を引き起こす可能性のある血液凝固を予防するのに役立ちます。凝固分析装置は、冠動脈バイパス手術や血管形成術の際に使用され、血液凝固状態に関する情報を監視します。このように、心血管疾患の罹患率の増加が凝固市場の成長を後押ししています。

凝固市場は、適応疾患、タイプ、提供、技術、エンドユーザー、地域によって区分されます。適応疾患別では、凝固市場はビタミンK欠乏症、肝疾患、播種性血管内凝固・肺塞栓症、循環性抗凝固薬開発、血友病、von Willebrand病、その他に区分されます。凝固市場はタイプ別に、臨床検査用分析装置とポイントオブケア検査用分析装置に区分されます。臨床検査分析装置は、コントロール＆キャリブレーター、アッセイ＆試薬、機器／システム、凝固因子、その他で構成されます。凝固市場は提供する製品によって診断と治療に区分されます。診断セグメントはさらに、プロトロンビン時間検査、フィブリノゲン検査、活性化凝固時間検査、活性化部分トロンボプラスチン時間検査、Dダイマー検査、血小板機能検査、その他に分類されます。治療分野はさらに、抗線溶薬、避妊薬、デスモプレシン＆免疫抑制薬、ビタミンKサプリメント、血液希釈薬、トロンビン阻害薬または血栓溶解薬、補充療法、カテーテル補助血栓除去、その他に分類されます。技術別では、凝固市場は光学技術、機械技術、電気化学技術、その他に区分されます。エンドユーザー別では、凝固市場は臨床検査室、病院、その他に区分されます。

地域別では、北米、欧州、アジア太平洋、中東・アフリカ、中南米に区分されます。北米は凝固市場で最大の市場シェアを占めています。北米は、血液疾患の増加、心房細動（AFib）などの心血管疾患の増加、新製品および既存製品の開発に従事する大手市場参入企業の存在により、大きな市場シェアを占めています。北米の凝固市場で最大のシェアを占めるのは米国です。血液疾患患者の急増、心血管疾患の有病率の増加、血液疾患予防のための政府支援などが、予測期間中の北米凝固市場の成長を後押しすると予想されます。カナダ予防医療タスクフォース（Canadian Task Force on Preventive Health Care）によると、カナダにおける心房細動の発症率は年間4.5%増加し、40歳以上の生涯リスクは25%に達します。約30万人のカナダ人が遺伝性の出血性疾患遺伝子を持っています。このうち10人に1人、少なくとも3万人のカナダ人が、医療を必要とするほど重篤な症状を持っています。その多くは適切な診断を受けていないです。遺伝性出血性疾患のための包括的ケアクリニックのカナダのネットワークに登録されている遺伝性出血性疾患の患者はわずか1万人です。カナダ血友病協会によると、30万人までのカナダ人が遺伝性血液疾患の遺伝子を持っています。したがって、先天性血液疾患の症例数の増加は、カナダにおける凝固市場の成長に関連する可能性があります。

米国心臓協会（AHA）、米国疾病予防管理センター（CDC）、欧州連合（EU）、カナダ予防医療タスクフォース（Canadian Task Force on Preventive Health Care）などは、凝固市場に関するレポート作成時に参照した一次情報および二次情報の一部です。

主な市場促進要因
- 市場促進要因
- 血液疾患の有病率の増加
- 心血管疾患の有病率の上昇
市場抑制要因
- 凝固分析装置に関連する高コスト
市場機会
- 主要市場参入企業による有機的・無機的戦略の成長
今後の動向
- ポイントオブケア（POC）凝固分析装置の発展
影響分析

第6章凝固市場-世界市場分析

凝固市場売上高、2022年～2030年
地域分析市場収益、2022年～2030年

第7章凝固の世界市場：適応疾患別収益と2030年までの予測

イントロダクション
凝固市場の適応疾患別収益シェア（2022年および2030年）
ビタミンK欠乏症
肝疾患
播種性血管内凝固症候群および肺塞栓症
循環型抗凝固薬の開発
血友病
フォンウィルブランド病
その他

第8章凝固の世界市場：タイプ別収益と2030年までの予測

イントロダクション
凝固市場のタイプ別収益シェア（2022年および2030年）
臨床検査分析装置
ポイントオブケア検査分析装置

第9章凝固の世界市場：収益と2030年までの予測：オファリング別

イントロダクション
凝固市場のオファリング別収益シェア（2022年および2030年）
診断
治療

第10章凝固の世界市場：技術別収益と2030年までの予測

イントロダクション
凝固市場の技術別収益シェア（2022年および2030年）
光学技術
機械的技術
電気化学技術
その他

第11章凝固の世界市場：エンドユーザー別収益と2030年までの予測

イントロダクション
凝固市場のエンドユーザー別収益シェア（2022年および2030年）
臨床検査機関
病院
その他

第12章凝固市場-地域別分析

北米
- メキシコ
欧州
- その他の欧州
アジア太平洋
- 太平洋
  - 中国
  - 日本
  - インド
  - オーストラリア
  - 韓国
  - その他のアジア太平洋
中東・アフリカ地域
- その他の中東およびアフリカ
中南米
- その他の中南米

第13章凝固市場-業界情勢

イントロダクション
凝固市場の成長戦略
無機的成長戦略
- 概要
有機的成長戦略
- 概要

第14章企業プロファイル

Siemens Healthineers AG
Diagnostica Stago, Inc
ImproGen Diagnostik Kimya San. & Tic. Ltd.
Nordic Biomarker AB
Sysmex Corp
Helena Laboratories Corporation
F. Hoffmann-La Roche Ltd
Genrui Biotech Co., Ltd.
Transasia Bio-Medicals Ltd
Horiba Ltd.

第15章付録

図表

List Of Tables

Table 1. Coagulation Market Segmentation
Table 2. Global Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 3. Global Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 4. Global Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 5. Optical Technologies and Their Applications
Table 6. Mechanical Technologies and Their Applications
Table 7. North America Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 8. North America Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 9. North America Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 10. North America Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 11. North America Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 12. North America Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 13. North America Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 14. North America Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 15. US Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 16. US Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 17. US Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 18. US Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 19. US Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 20. US Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 21. US Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 22. US Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 23. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 24. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 25. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 26. Canada Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 27. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 28. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 29. Canada Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 30. Canada Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 31. Mexico Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 32. Mexico Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 33. Mexico Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 34. Mexico Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 35. Mexico Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 36. US Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 37. Mexico Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 38. Mexico Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 39. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 40. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 41. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 42. Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 43. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 44. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 45. Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 46. Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 47. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 48. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 49. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 50. Germany Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 51. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 52. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 53. Germany Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 54. Germany Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 55. UK Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 56. UK Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 57. UK Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 58. UK Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 59. UK Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 60. UK Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 61. UK Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 62. UK Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 63. France Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 64. France Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 65. France Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 66. France Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 67. France Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 68. France Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 69. France Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 70. France Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 71. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 72. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 73. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 74. Italy Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 75. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 76. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 77. Italy Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 78. Italy Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 79. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 80. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 81. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 82. Spain Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 83. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 84. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 85. Spain Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 86. Spain Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 87. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Disease Indication
Table 88. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Type
Table 89. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Clinical Laboratory Analyzers
Table 90. Rest of Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) - Offering
Table 91. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Diagnosis
Table 92. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) - Treatment
Table 93. Rest of Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) - Technology
Table 94. Rest of Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) - End User
Table 95. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 96. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 97. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 98. Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 99. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 100. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 101. Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 102. Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 103. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 104. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 105. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 106. China Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 107. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 108. China Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 109. China Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 110. China Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 111. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 112. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 113. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 114. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 115. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 116. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 117. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 118. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 119. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 120. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 121. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 122. India Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 123. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 124. India Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 125. India Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 126. India Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 127. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 128. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 129. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 130. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 131. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 132. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 133. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 134. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 135. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 136. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 137. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 138. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 139. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 140. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 141. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 142. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 143. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 144. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 145. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 146. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 147. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 148. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 149. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 150. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 151. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 152. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 153. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 154. Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 155. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 156. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 157. Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 158. Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 159. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 160. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 161. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 162. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 163. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 164. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 165. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 166. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 167. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 168. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 169. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 170. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 171. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 172. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 173. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 174. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 175. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 176. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 177. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 178. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 179. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 180. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 181. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 182. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 183. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 184. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 185. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 186. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 187. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 188. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 189. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 190. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 191. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 192. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 193. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 194. South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 195. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 196. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 197. South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 198. South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 199. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 200. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 201. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 202. Brazil Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 203. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 204. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 205. Brazil Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 206. Brazil Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 207. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 208. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 209. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 210. Argentina Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 211. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 212. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 213. Argentina Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 214. Argentina Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 215. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Disease Indication
Table 216. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Type
Table 217. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Clinical Laboratory Analyzer
Table 218. Rest of South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) - Offering
Table 219. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Diagnosis
Table 220. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) - Treatment
Table 221. Rest of South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) - Technology
Table 222. Rest of South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) - End User
Table 223. Recent Inorganic Growth Strategies in the Coagulation Market
Table 224. Recent Organic Growth Strategies in the Coagulation Market
Table 225. Glossary of Terms, Coagulation Market

List Of Figures

Figure 1. Coagulation Market Segmentation, By Geography
Figure 2. North America - PEST Analysis
Figure 3. Coagulation Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Coagulation Market Revenue (US$ million), 2020 - 2030
Figure 6. Geography Analysis Market Revenue (US$ million), 2022 - 2030
Figure 7. Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
Figure 8. Vitamin K Deficiency: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Liver Disease: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Disseminated Intravascular Coagulation and Pulmonary Embolism: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Development of Circulating Anticoagulant: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Hemophilia: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Von Willebrand's Disease: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
Figure 16. Clinical Laboratory Analyzers: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Point-of-Care Testing Analyzers: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
Figure 19. Diagnosis: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Treatment: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 22. Optical Technology: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Mechanical Technology: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Electrochemical Technology: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Others: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
Figure 27. Clinical Laboratories: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Hospitals: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Others: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Coagulation Market, 2022 ($million)
Figure 31. North America Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 32. North America Coagulation Market, By Key Countries, 2022 And 2030 (%)
Figure 33. US Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 34. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 35. Mexico Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 36. Europe Coagulation Market, By Geography, 2022 ($million)
Figure 37. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 38. Europe Coagulation Market, By Key Countries, 2022 And 2030 (%)
Figure 39. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 40. UK Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 41. France Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 42. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 43. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 44. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 45. Coagulation Market, By Geography, 2022 (US$ Million)
Figure 46. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 47. Asia Pacific Coagulation Market, By Key Countries, 2022 And 2030 (%)
Figure 48. China Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 49. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 50. India Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 51. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 52. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 53. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 54. Coagulation Market, By Geography, 2022 And 2030 ($million)
Figure 55. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 56. Middle East & Africa Coagulation Market, By Key Countries, 2022 And 2030 (%)
Figure 57. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 58. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 59. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 60. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 61. Coagulation Market, By Geography, 2022 ($million)
Figure 62. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 63. South & Central America Coagulation Market, By Key Countries, 2022 And 2030 (%)
Figure 64. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 65. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 66. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 67. Growth Strategies in the Coagulation Market

Product Code: TIPRE00030085

The coagulation market is expected to grow from US$ 6.295 billion in 2022 to US$ 10.853 billion by 2030; it is anticipated to record a CAGR of 7.0% from 2022 to 2030.

Changing lifestyle habits and a growing geriatric population are among the major factors increasing the prevalence of blood disorders. Therefore, there is a growing demand for early diagnosis and treatment. Key players are taking several initiatives through various organic and inorganic strategies to enhance the quality of life of patient population.

In July 2020, Sysmex Corporation launched the Automated Blood Coagulation Analyzers CN-6500/CN-3500 in Japan. The analyzer measures blood coagulation and platelet aggregation parameters, as well as thrombosis and hemostasis parameters.

In April 2020, US-based Haemonetics Corporation acquired Enicor, a blood coagulation diagnostic system developer.

In October 2021, Trivitron Healthcare launched a new line of coagulation analyzer products manufactured by Diagon Ltd in India.

In June 2021, Trivitron Healthcare introduced NANO H5 and NANO H110, which help in monitoring diabetes, hemoglobin variations, and thalassemia.

In February 2021, Siemens Healthineers and Sysmex Corporation renewed their agreement to supply, distribute, sell, and service hemostasis products across the world. The agreement also included an extension for multiple years. Further, Siemens Healthineers agreed to distribute Sysmex's automated blood coagulation analyzer, such as the CN-3000 and CN-6000.

In July 2022, HORIBA Medical launched the latest Yumizen G800 and G1550 hemostasis analyzers, as well as a range of convenient ready-to-use reagents for common blood coagulation tests. With this expansion of its product line, HORIBA Medical now offers a comprehensive selection of hemostasis systems and advanced reagents for laboratories of all sizes and requirements.

Thus, the adoption of various organic and inorganic strategies by the key market players is expected to provide opportunities for the coagulation market growth during the forecast period.

Rising Prevalence of Cardiovascular Diseases drives the growth the Coagulation Market

Heart disease is one of the leading causes of hospitalization, death, and reduced physical performance due to conditions such as atrial fibrillation and stroke. It affects the hemostatic system, vascular system, and fluid dynamics of blood and causes arterial and venous thrombosis. Thrombosis is the leading cause of death and complications from cardiovascular disease. Blood vessels damaged by smoking and high blood pressure form cholesterol-rich plaques lining the blood vessels, which can rupture and cause platelets to clot. With coagulation disorders, there is a risk of myocardial infarction, stroke, and atherothrombotic events in the vascular beds. Heart failure (HF) is related to an increased risk of thromboembolism independent of the presence of atrial fibrillation (AF). Platelet activation and coagulation system abnormalities can increase the risk of serious thromboembolic events in patients suffering from HF.

According to the 2022 Heart Disease & Stroke Statistical Update Fact Sheet, ~119.1 million deaths due to CVDs and around 89.1 million and 68.2 million stroke and ischemic stroke cases, respectively, are recorded across the world in 2020. Per the National Center for Chronic Disease Prevention and Health Promotion, in 2023, the US reports ~877,500 deaths due to heart diseases every year. According to the American Heart Association, more than 130 million Americans are likely to acquire some form of CVD by 2035. As per 'Global Burden of Disease Study 2019,' CVDs were the leading cause of deaths in Asia Pacific in 2019, causing 10.8 million or 35% of the total fatalities.

A coagulation test helps prevent potential heart attack-causing blood clotting. A coagulation analyzer is used during coronary artery bypass surgery and angioplasty to monitor information on blood clotting status. Thus, the growing incidence of cardiovascular diseases bolsters the coagulation market growth.

The coagulation market is segmented on the basis of disease indication, type, offering, technology, end user, and geography. Based on disease indication, the coagulation market is segmented into vitamin K deficiency, liver disease, disseminated intravascular coagulation & pulmonary embolism, circulating anticoagulant development, hemophilia, von Willebrand's disease, and others. Based on type, the coagulation market is segmented into clinical laboratory analyzers and point-of-care testing analyzers. Clinical laboratory analyzers consist of controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others. Based on offering, the coagulation market is segmented into diagnosis and treatment. The diagnosis segment is further classified into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, D-dimmer testing, platelets function testing, and others. The treatment segment is further classified into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin K supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapies, catheter-assisted thrombus removal, and others. Based on technology, the coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. Based on end user, the coagulation market is segmented into clinical laboratories, hospitals, and others.

Based on geography, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share of the coagulation market. North America accounts for a significant market share owing to the growing incidences of blood disorders, increasing occurrence of cardiovascular diseases such as atrial fibrillation (AFib), and the presence of major market players engaged in new and existing product developments. The US holds the largest share of the coagulation market in North America. The burgeoning cases of blood disorders, growing prevalence of cardiovascular diseases, and government support for preventing blood disorders are anticipated to boost the North America coagulation market growth during the forecast period. As per the Canadian Task Force on Preventive Health Care, the incidence of AFib in Canada increases by 4.5% per year, with a lifetime risk of ~25% among people aged more than 40 years. Approximately 300,000 Canadians carry an inherited bleeding disorder gene. 1 in 10 of these people-at least 30,000 Canadians-have symptoms severe enough to require medical care. Many of them have not been properly diagnosed. Only 10,000 people with inherited bleeding disorders are registered in the Canadian network of comprehensive care clinics for inherited bleeding disorders. According to the Canadian Hemophilia Society, ~300,000 Canadians carry a gene for an inherited blood disorder. Thus, the rising number of cases of congenital blood disorders can be associated with the growth of the coagulation market in Canada.

American Heart Association (AHA), Centers for Disease Control and Prevention (CDC), European Union, and Canadian Task Force on Preventive Health Care are a few key primary and secondary sources referred to while preparing the report on the coagulation market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the coagulation market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the coagulation market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the coagulation market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Coagulation Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Coagulation Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Market Drivers
- 5.1.2 Increasing Prevalence of Blood Disorders
- 5.1.3 Rising Prevalence of Cardiovascular Diseases
5.2 Market Restraints
- 5.2.1 High Costs Associated with Coagulation Analyzers
5.3 Market Opportunities
- 5.3.1 Growing Organic and Inorganic Strategies by Key Market Players
5.4 Future Trends
- 5.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
5.5 Impact Analysis

6. Coagulation Market - Global Market Analysis

6.1 Coagulation Market Revenue (US$ million), 2022 - 2030
6.2 Geography Analysis Market Revenue (US$ million), 2022 - 2030

7. Global Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication

7.1 Overview
7.2 Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
7.3 Vitamin K Deficiency
- 7.3.1 Overview
- 7.3.2 Vitamin K Deficiency: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Liver Disease
- 7.4.1 Overview
- 7.4.2 Liver Disease: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
- 7.5.1 Overview
- 7.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Development of Circulating Anticoagulant
- 7.6.1 Overview
- 7.6.2 Development of Circulating Anticoagulant: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Hemophilia
- 7.7.1 Overview
- 7.7.2 Hemophilia: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Von Willebrand's Disease
- 7.8.1 Overview
- 7.8.2 Von Willebrand's Disease: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
7.9 Others
- 7.9.1 Overview
- 7.9.2 Others: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Coagulation Market - Revenue and Forecast to 2030 - by Type

8.1 Overview
8.2 Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
8.3 Clinical Laboratory Analyzers
- 8.3.1 Overview
- 8.3.2 Clinical Laboratory Analyzers: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 Global Coagulation Market, by Clinical Laboratory Analyzers
8.4 Point-of-Care Testing Analyzers
- 8.4.1 Overview
- 8.4.2 Point-of-Care Testing Analyzers: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Coagulation Market - Revenue and Forecast to 2030 - by Offering

9.1 Overview
9.2 Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
9.3 Diagnosis
- 9.3.1 Overview
- 9.3.2 Diagnosis: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 9.3.2.1 Global Coagulation Market, by Diagnosis
9.4 Treatment
- 9.4.1 Overview
- 9.4.2 Treatment: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
  - 9.4.2.1 Global Coagulation Market, by Treatment

10. Global Coagulation Market - Revenue and Forecast to 2030 - by Technology

10.1 Overview
10.2 Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
10.3 Optical Technology
- 10.3.1 Overview
- 10.3.2 Optical Technology: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Mechanical Technology
- 10.4.1 Overview
- 10.4.2 Mechanical Technology: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Electrochemical Technology
- 10.5.1 Overview
- 10.5.2 Electrochemical Technology: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

11. Global Coagulation Market - Revenue and Forecast to 2030 - by End User

11.1 Overview
11.2 Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
11.3 Clinical Laboratories
- 11.3.1 Overview
- 11.3.2 Clinical Laboratories: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
11.4 Hospitals
- 11.4.1 Overview
- 11.4.2 Hospitals: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
11.5 Others
- 11.5.1 Overview
- 11.5.2 Others: Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

12. Coagulation Market - Geographical Analysis

12.1 North America Coagulation Market, Revenue And Forecast To 2030
- 12.1.1 Overview
- 12.1.2 North America Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 12.1.3 North America Coagulation Market, by Disease Indication
- 12.1.4 North America Coagulation Market, by Type
  - 12.1.4.1 North America Coagulation Market, by Clinical Laboratory Analyzers
- 12.1.5 North America Coagulation Market, by Offering
  - 12.1.5.1 North America Coagulation Market, by Diagnosis
  - 12.1.5.2 North America Coagulation Market, by Treatment
- 12.1.6 North America Coagulation Market, by Technology
- 12.1.7 North America Coagulation Market, by End User
  - 12.1.7.1 North America Coagulation Market, by Country
  - 12.1.7.2 US
    - 12.1.7.2.1 Overview
    - 12.1.7.2.2 US Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.1.7.2.3 US Coagulation Market, by Disease Indication
    - 12.1.7.2.4 US Coagulation Market, by Type
    - 12.1.7.2.4.1 US Coagulation Market, by Clinical Laboratory Analyzers
    - 12.1.7.2.5 US Coagulation Market, by Offering
    - 12.1.7.2.5.1 US Coagulation Market, by Diagnosis
    - 12.1.7.2.5.2 US Coagulation Market, by Treatment
    - 12.1.7.2.6 US Coagulation Market, by Technology
    - 12.1.7.2.7 US Coagulation Market, by End User
  - 12.1.7.3 Canada
    - 12.1.7.3.1 Overview
    - 12.1.7.3.2 Canada Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.1.7.3.3 Canada Coagulation Market, by Disease Indication
    - 12.1.7.3.4 Canada Coagulation Market, by Type
    - 12.1.7.3.4.1 Canada Coagulation Market, by Clinical Laboratory Analyzers
    - 12.1.7.3.5 Canada Coagulation Market, by Offering
    - 12.1.7.3.5.1 Canada Coagulation Market, by Diagnosis
    - 12.1.7.3.5.2 Canada Coagulation Market, by Treatment
    - 12.1.7.3.6 Canada Coagulation Market, by Technology
    - 12.1.7.3.7 Canada Coagulation Market, by End User
  - 12.1.7.4 Mexico
    - 12.1.7.4.1 Overview
    - 12.1.7.4.2 Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.1.7.4.3 Mexico Coagulation Market, by Disease Indication
    - 12.1.7.4.4 Mexico Coagulation Market, by Type
    - 12.1.7.4.4.1 Mexico Coagulation Market, by Clinical Laboratory Analyzers
    - 12.1.7.4.5 Mexico Coagulation Market, by Offering
    - 12.1.7.4.5.1 Mexico Coagulation Market, by Diagnosis
    - 12.1.7.4.5.2 US Coagulation Market, by Treatment
    - 12.1.7.4.6 Mexico Coagulation Market, by Technology
    - 12.1.7.4.7 Mexico Coagulation Market, by End User
12.2 Europe Coagulation Market, Revenue And Forecast to 2030
- 12.2.1 Overview
- 12.2.2 Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 12.2.3 Europe Coagulation Market, by Disease Indication
- 12.2.4 Europe Coagulation Market, by Type
  - 12.2.4.1 Europe Coagulation Market, by Clinical Laboratory Analyzers
- 12.2.5 Europe Coagulation Market, by Offering
  - 12.2.5.1 Europe Coagulation Market, by Diagnosis
  - 12.2.5.2 Europe Coagulation Market, by Treatment
- 12.2.6 Europe Coagulation Market, by Technology
- 12.2.7 Europe Coagulation Market, by End User
- 12.2.8 Europe Coagulation Market by Country
  - 12.2.8.1 Germany
    - 12.2.8.1.1 Overview
    - 12.2.8.1.2 Germany Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.1.3 Germany Coagulation Market, by Disease Indication
    - 12.2.8.1.4 Germany Coagulation Market, by Type
    - 12.2.8.1.4.1 Germany Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.1.5 Germany Coagulation Market, by Offering
    - 12.2.8.1.5.1 Germany Coagulation Market, by Diagnosis
    - 12.2.8.1.5.2 Germany Coagulation Market, by Treatment
    - 12.2.8.1.6 Germany Coagulation Market, by Technology
    - 12.2.8.1.7 Germany Coagulation Market, by End User
  - 12.2.8.2 UK
    - 12.2.8.2.1 Overview
    - 12.2.8.2.1.1 UK Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.2.2 UK Coagulation Market, by Disease Indication
    - 12.2.8.2.3 UK Coagulation Market, by Type
    - 12.2.8.2.3.1 UK Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.2.4 UK Coagulation Market, by Offering
    - 12.2.8.2.4.1 UK Coagulation Market, by Diagnosis
    - 12.2.8.2.4.2 UK Coagulation Market, by Treatment
    - 12.2.8.2.5 UK Coagulation Market, by Technology
    - 12.2.8.2.6 UK Coagulation Market, by End User
  - 12.2.8.3 France
    - 12.2.8.3.1 Overview
    - 12.2.8.3.1.1 France Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.3.2 France Coagulation Market, by Disease Indication
    - 12.2.8.3.3 France Coagulation Market, by Type
    - 12.2.8.3.3.1 France Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.3.4 France Coagulation Market, by Offering
    - 12.2.8.3.4.1 France Coagulation Market, by Diagnosis
    - 12.2.8.3.4.2 France Coagulation Market, by Treatment
    - 12.2.8.3.5 France Coagulation Market, by Technology
    - 12.2.8.3.6 France Coagulation Market, by End User
  - 12.2.8.4 Italy
    - 12.2.8.4.1 Overview
    - 12.2.8.4.1.1 Italy Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.4.2 Italy Coagulation Market, by Disease Indication
    - 12.2.8.4.3 Italy Coagulation Market, by Type
    - 12.2.8.4.3.1 Italy Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.4.4 Italy Coagulation Market, by Offering
    - 12.2.8.4.4.1 Italy Coagulation Market, by Diagnosis
    - 12.2.8.4.4.2 Italy Coagulation Market, by Treatment
    - 12.2.8.4.5 Italy Coagulation Market, by Technology
    - 12.2.8.4.6 Italy Coagulation Market, by End User
  - 12.2.8.5 Spain
    - 12.2.8.5.1 Overview
    - 12.2.8.5.2 Spain Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.5.3 Spain Coagulation Market, by Disease Indication
    - 12.2.8.5.4 Spain Coagulation Market, by Type
    - 12.2.8.5.4.1 Spain Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.5.5 Spain Coagulation Market, by Offering
    - 12.2.8.5.5.1 Spain Coagulation Market, by Diagnosis
    - 12.2.8.5.5.2 Spain Coagulation Market, by Treatment
    - 12.2.8.5.6 Spain Coagulation Market, by Technology
    - 12.2.8.5.7 Spain Coagulation Market, by End User
  - 12.2.8.6 Rest of Europe
    - 12.2.8.6.1 Overview
    - 12.2.8.6.2 Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.2.8.6.3 Rest of Europe Coagulation Market, by Disease Indication
    - 12.2.8.6.4 Rest of Europe Coagulation Market, by Type
    - 12.2.8.6.4.1 Rest of Europe Coagulation Market, by Clinical Laboratory Analyzers
    - 12.2.8.6.5 Rest of Europe Coagulation Market, by Offering
    - 12.2.8.6.5.1 Rest of Europe Coagulation Market, by Diagnosis
    - 12.2.8.6.5.2 Rest of Europe Coagulation Market, by Treatment
    - 12.2.8.6.6 Rest of Europe Coagulation Market, by Technology
    - 12.2.8.6.7 Rest of Europe Coagulation Market, by End User
12.3 Asia Pacific Coagulation Market, Revenue and Forecast to 2030
- 12.3.1 Overview
- 12.3.2 Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 12.3.3 Asia Pacific Coagulation Market, by Disease Indication
- 12.3.4 Asia Pacific Coagulation Market, by Type
  - 12.3.4.1 Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer
- 12.3.5 Asia Pacific Coagulation Market, by Offering
  - 12.3.5.1 Asia Pacific Coagulation Market, by Diagnosis
  - 12.3.5.2 Asia Pacific Coagulation Market, by Treatment
- 12.3.6 Asia Pacific Coagulation Market, by Technology
- 12.3.7 Asia Pacific Coagulation Market, by End User
- 12.3.8 Asia Pacific Coagulation Market by Country
  - 12.3.8.1 China
    - 12.3.8.1.1 Overview
    - 12.3.8.1.2 China Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.1.3 China Coagulation Market, by Disease Indication
    - 12.3.8.1.4 China Coagulation Market, by Type
    - 12.3.8.1.4.1 China Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.1.5 China Coagulation Market, by Offering
    - 12.3.8.1.5.1 China Coagulation Market, by Diagnosis
    - 12.3.8.1.5.2 China Coagulation Market, by Treatment
    - 12.3.8.1.6 China Coagulation Market, by Technology
    - 12.3.8.1.7 China Coagulation Market, by End User
  - 12.3.8.2 Japan
    - 12.3.8.2.1 Overview
    - 12.3.8.2.2 Japan Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.2.3 Japan Coagulation Market, by Disease Indication
    - 12.3.8.2.4 Japan Coagulation Market, by Type
    - 12.3.8.2.4.1 Japan Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.2.5 Japan Coagulation Market, by Offering
    - 12.3.8.2.5.1 Japan Coagulation Market, by Diagnosis
    - 12.3.8.2.5.2 Japan Coagulation Market, by Treatment
    - 12.3.8.2.6 Japan Coagulation Market, by Technology
    - 12.3.8.2.7 Japan Coagulation Market, by End User
  - 12.3.8.3 India
    - 12.3.8.3.1 Overview
    - 12.3.8.3.2 India Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.3.3 India Coagulation Market, by Disease Indication
    - 12.3.8.3.4 India Coagulation Market, by Type
    - 12.3.8.3.4.1 India Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.3.5 India Coagulation Market, by Offering
    - 12.3.8.3.5.1 India Coagulation Market, by Diagnosis
    - 12.3.8.3.5.2 India Coagulation Market, by Treatment
    - 12.3.8.3.6 India Coagulation Market, by Technology
    - 12.3.8.3.7 India Coagulation Market, by End User
  - 12.3.8.4 Australia
    - 12.3.8.4.1 Overview
    - 12.3.8.4.2 Australia Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.4.3 Australia Coagulation Market, by Disease Indication
    - 12.3.8.4.4 Australia Coagulation Market, by Type
    - 12.3.8.4.4.1 Australia Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.4.5 Australia Coagulation Market, by Offering
    - 12.3.8.4.5.1 Australia Coagulation Market, by Diagnosis
    - 12.3.8.4.5.2 Australia Coagulation Market, by Treatment
    - 12.3.8.4.6 Australia Coagulation Market, by Technology
    - 12.3.8.4.7 Australia Coagulation Market, by End User
  - 12.3.8.5 South Korea
    - 12.3.8.5.1 Overview
    - 12.3.8.5.2 South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.5.3 South Korea Coagulation Market, by Disease Indication
    - 12.3.8.5.4 South Korea Coagulation Market, by Type
    - 12.3.8.5.4.1 South Korea Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.5.5 South Korea Coagulation Market, by Offering
    - 12.3.8.5.5.1 South Korea Coagulation Market, by Diagnosis
    - 12.3.8.5.5.2 South Korea Coagulation Market, by Treatment
    - 12.3.8.5.6 South Korea Coagulation Market, by Technology
    - 12.3.8.5.7 South Korea Coagulation Market, by End User
  - 12.3.8.6 Rest of Asia Pacific
    - 12.3.8.6.1 Overview
    - 12.3.8.6.2 Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.3.8.6.3 Rest of Asia Pacific Coagulation Market, by Disease Indication
    - 12.3.8.6.4 Rest of Asia Pacific Coagulation Market, by Type
    - 12.3.8.6.4.1 Rest of Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer
    - 12.3.8.6.5 Rest of Asia Pacific Coagulation Market, by Offering
    - 12.3.8.6.5.1 Rest of Asia Pacific Coagulation Market, by Diagnosis
    - 12.3.8.6.5.2 Rest of Asia Pacific Coagulation Market, by Treatment
    - 12.3.8.6.6 Rest of Asia Pacific Coagulation Market, by Technology
    - 12.3.8.6.7 Rest of Asia Pacific Coagulation Market, by End User
12.4 Middle East & Africa Coagulation Market, Revenue and Forecast to 2030
- 12.4.1 Overview
- 12.4.2 Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 12.4.3 Middle East & Africa Coagulation Market, by Disease Indication
- 12.4.4 Middle East & Africa Coagulation Market, by Type
  - 12.4.4.1 Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer
- 12.4.5 Middle East & Africa Coagulation Market, by Offering
  - 12.4.5.1 Middle East & Africa Coagulation Market, by Diagnosis
  - 12.4.5.2 Middle East & Africa Coagulation Market, by Treatment
- 12.4.6 Middle East & Africa Coagulation Market, by Technology
- 12.4.7 Middle East & Africa Coagulation Market, by End User
  - 12.4.7.1 Middle East & Africa Coagulation Market by Country
  - 12.4.7.2 Saudi Arabia
    - 12.4.7.2.1 Overview
    - 12.4.7.2.2 Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.4.7.2.3 Saudi Arabia Coagulation Market, by Disease Indication
    - 12.4.7.2.4 Saudi Arabia Coagulation Market, by Type
    - 12.4.7.2.4.1 Saudi Arabia Coagulation Market, by Clinical Laboratory Analyzer
    - 12.4.7.2.5 Saudi Arabia Coagulation Market, by Offering
    - 12.4.7.2.5.1 Saudi Arabia Coagulation Market, by Diagnosis
    - 12.4.7.2.5.2 Saudi Arabia Coagulation Market, by Treatment
    - 12.4.7.2.6 Saudi Arabia Coagulation Market, by Technology
    - 12.4.7.2.7 Saudi Arabia Coagulation Market, by End User
  - 12.4.7.3 South Africa
    - 12.4.7.3.1 Overview
    - 12.4.7.3.2 South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.4.7.3.3 South Africa Coagulation Market, by Disease Indication
    - 12.4.7.3.4 South Africa Coagulation Market, by Type
    - 12.4.7.3.4.1 South Africa Coagulation Market, by Clinical Laboratory Analyzer
    - 12.4.7.3.5 South Africa Coagulation Market, by Offering
    - 12.4.7.3.5.1 South Africa Coagulation Market, by Diagnosis
    - 12.4.7.3.5.2 South Africa Coagulation Market, by Treatment
    - 12.4.7.3.6 South Africa Coagulation Market, by Technology
    - 12.4.7.3.7 South Africa Coagulation Market, by End User
  - 12.4.7.4 UAE
    - 12.4.7.4.1 Overview
    - 12.4.7.4.2 UAE Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.4.7.4.3 UAE Coagulation Market, by Disease Indication
    - 12.4.7.4.4 UAE Coagulation Market, by Type
    - 12.4.7.4.4.1 UAE Coagulation Market, by Clinical Laboratory Analyzer
    - 12.4.7.4.5 UAE Coagulation Market, by Offering
    - 12.4.7.4.5.1 UAE Coagulation Market, by Diagnosis
    - 12.4.7.4.5.2 UAE Coagulation Market, by Treatment
    - 12.4.7.4.6 UAE Coagulation Market, by Technology
    - 12.4.7.4.7 UAE Coagulation Market, by End User
  - 12.4.7.5 Rest of Middle East & Africa
    - 12.4.7.5.1 Overview
    - 12.4.7.5.2 Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.4.7.5.3 Rest of Middle East & Africa Coagulation Market, by Disease Indication
    - 12.4.7.5.4 Rest of Middle East & Africa Coagulation Market, by Type
    - 12.4.7.5.4.1 Rest of Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer
    - 12.4.7.5.5 Rest of Middle East & Africa Coagulation Market, by Offering
    - 12.4.7.5.5.1 Rest of Middle East & Africa Coagulation Market, by Diagnosis
    - 12.4.7.5.5.2 Rest of Middle East & Africa Coagulation Market, by Treatment
    - 12.4.7.5.6 Rest of Middle East & Africa Coagulation Market, by Technology
    - 12.4.7.5.7 Rest of Middle East & Africa Coagulation Market, by End User
12.5 South & Central America Coagulation Market, Revenue and Forecast to 2030
- 12.5.1 Overview
- 12.5.2 South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
- 12.5.3 South & Central America Coagulation Market, by Disease Indication
- 12.5.4 South & Central America Coagulation Market, by Type
  - 12.5.4.1 South & Central America Coagulation Market, by Clinical Laboratory Analyzer
- 12.5.5 South & Central America Coagulation Market, by Offering
  - 12.5.5.1 South & Central America Coagulation Market, by Diagnosis
  - 12.5.5.2 South & Central America Coagulation Market, by Treatment
- 12.5.6 South & Central America Coagulation Market, by Technology
- 12.5.7 South & Central America Coagulation Market, by End User
- 12.5.8 South & Central America Coagulation Market by Country
  - 12.5.8.1 Brazil
    - 12.5.8.1.1 Overview
    - 12.5.8.1.2 Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.5.8.1.3 Brazil Coagulation Market, by Disease Indication
    - 12.5.8.1.4 Brazil Coagulation Market, by Type
    - 12.5.8.1.4.1 Brazil Coagulation Market, by Clinical Laboratory Analyzer
    - 12.5.8.1.5 Brazil Coagulation Market, by Offering
    - 12.5.8.1.5.1 Brazil Coagulation Market, by Diagnosis
    - 12.5.8.1.5.2 Brazil Coagulation Market, by Treatment
    - 12.5.8.1.6 Brazil Coagulation Market, by Technology
    - 12.5.8.1.7 Brazil Coagulation Market, by End User
  - 12.5.8.2 Argentina
    - 12.5.8.2.1 Overview
    - 12.5.8.2.2 Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.5.8.2.3 Argentina Coagulation Market, by Disease Indication
    - 12.5.8.2.4 Argentina Coagulation Market, by Type
    - 12.5.8.2.4.1 Argentina Coagulation Market, by Clinical Laboratory Analyzer
    - 12.5.8.2.5 Argentina Coagulation Market, by Offering
    - 12.5.8.2.5.1 Argentina Coagulation Market, by Diagnosis
    - 12.5.8.2.5.2 Argentina Coagulation Market, by Treatment
    - 12.5.8.2.6 Argentina Coagulation Market, by Technology
    - 12.5.8.2.7 Argentina Coagulation Market, by End User
  - 12.5.8.3 Rest of South & Central America
    - 12.5.8.3.1 Overview
    - 12.5.8.3.2 Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
    - 12.5.8.3.3 Rest of South & Central America Coagulation Market, by Disease Indication
    - 12.5.8.3.4 Rest of South & Central America Coagulation Market, by Type
    - 12.5.8.3.4.1 Rest of South & Central America Coagulation Market, by Clinical Laboratory Analyzer
    - 12.5.8.3.5 Rest of South & Central America Coagulation Market, by Offering
    - 12.5.8.3.5.1 Rest of South & Central America Coagulation Market, by Diagnosis
    - 12.5.8.3.5.2 Rest of South & Central America Coagulation Market, by Treatment
    - 12.5.8.3.6 Rest of South & Central America Coagulation Market, by Technology
    - 12.5.8.3.7 Rest of South & Central America Coagulation Market, by End User

13. Coagulation Market-Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Coagulation Market
13.3 Inorganic Growth Strategies
- 13.3.1 Overview
13.4 Organic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Siemens Healthineers AG
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Diagnostica Stago, Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 ImproGen Diagnostik Kimya San. & Tic. Ltd.?ti.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Nordic Biomarker AB
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Sysmex Corp
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Helena Laboratories Corporation
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 F. Hoffmann-La Roche Ltd
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Genrui Biotech Co., Ltd.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Transasia Bio-Medicals Ltd
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Horiba Ltd.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About Us
15.2 Glossary of Terms

凝固市場規模および予測、世界および地域シェア、動向、成長機会分析レポート対象範囲：適応疾患別、タイプ別、オファリング別、技術別、エンドユーザー別、地域別

Coagulation Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Indications, Type, Offering, Technology, End User, and Geography

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章凝固市場の情勢

第5章凝固市場：主要産業力学

第6章凝固市場-世界市場分析

第7章凝固の世界市場：適応疾患別収益と2030年までの予測

第8章凝固の世界市場：タイプ別収益と2030年までの予測

第9章凝固の世界市場：収益と2030年までの予測：オファリング別

第10章凝固の世界市場：技術別収益と2030年までの予測

第11章凝固の世界市場：エンドユーザー別収益と2030年までの予測

第12章凝固市場-地域別分析

第13章凝固市場-業界情勢

第14章企業プロファイル

第15章付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Coagulation Market Landscape

5. Coagulation Market - Key Industry Dynamics

6. Coagulation Market - Global Market Analysis

7. Global Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication

8. Global Coagulation Market - Revenue and Forecast to 2030 - by Type

9. Global Coagulation Market - Revenue and Forecast to 2030 - by Offering

10. Global Coagulation Market - Revenue and Forecast to 2030 - by Technology

11. Global Coagulation Market - Revenue and Forecast to 2030 - by End User

12. Coagulation Market - Geographical Analysis

13. Coagulation Market-Industry Landscape

14. Company Profiles

15. Appendix

凝固市場規模および予測、世界および地域シェア、動向、成長機会分析レポート対象範囲：適応疾患別、タイプ別、オファリング別、技術別、エンドユーザー別、地域別

Coagulation Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Indications, Type, Offering, Technology, End User, and Geography

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 凝固市場の情勢

第5章 凝固市場：主要産業力学

第6章 凝固市場-世界市場分析

第7章 凝固の世界市場：適応疾患別収益と2030年までの予測

第8章 凝固の世界市場：タイプ別収益と2030年までの予測

第9章 凝固の世界市場：収益と2030年までの予測：オファリング別

第10章 凝固の世界市場：技術別収益と2030年までの予測

第11章 凝固の世界市場：エンドユーザー別収益と2030年までの予測

第12章 凝固市場-地域別分析

第13章 凝固市場-業界情勢

第14章 企業プロファイル

第15章 付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Coagulation Market Landscape

5. Coagulation Market - Key Industry Dynamics

6. Coagulation Market - Global Market Analysis

7. Global Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication

8. Global Coagulation Market - Revenue and Forecast to 2030 - by Type

9. Global Coagulation Market - Revenue and Forecast to 2030 - by Offering

10. Global Coagulation Market - Revenue and Forecast to 2030 - by Technology

11. Global Coagulation Market - Revenue and Forecast to 2030 - by End User

12. Coagulation Market - Geographical Analysis

13. Coagulation Market-Industry Landscape

14. Company Profiles

15. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章凝固市場の情勢

第5章凝固市場：主要産業力学

第6章凝固市場-世界市場分析

第7章凝固の世界市場：適応疾患別収益と2030年までの予測

第8章凝固の世界市場：タイプ別収益と2030年までの予測

第9章凝固の世界市場：収益と2030年までの予測：オファリング別

第10章凝固の世界市場：技術別収益と2030年までの予測

第11章凝固の世界市場：エンドユーザー別収益と2030年までの予測

第12章凝固市場-地域別分析

第13章凝固市場-業界情勢

第14章企業プロファイル

第15章付録